In what could mark a watershed in the fight against HIV/AIDS, a panel of experts recommended that the Food and Drug Administration give a green light to a pill that can cut the risk of infections.
The daily pill, Truvada, made by Gilead Sciences, combines two medicines that inhibit the reproduction of HIV. It's already approved as a treatment for HIV, but its use could soon expand to include protection of uninfected people.
Washington state is in the midst of a whooping cough outbreak. The state has more than 1,100 confirmed cases so far this year — that's 10 times as many as this time last year, and health officials fear the number may rise.
The state is desperately trying to raise awareness of the epidemic. Take this public service announcement featuring a mother whose baby contracted the disease.
Originally published on Fri April 27, 2012 3:24 pm
It's no secret that Americans are short on sleep. But there's been disagreement as to why. A new study says here's one big reason: work.
An analysis from the National Institute for Occupational Safety and Health asked people where they're working, and how much they sleep. The more people work, the less sleep they're likely to get. And some jobs are much less sleep-friendly than others. Sort of saw those coming, even through our bleary eyes.